Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

(2014) T Brown et al.   HEALTH TECHNOLOGY ASSESSMENT

SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin

(2013) D. H. Shin et al.   CANCER RESEARCH

Targeted therapy for non-small-cell lung cancer: past, present and future

(2013) Patrick M Forde et al.   Expert Review of Anticancer Therapy

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

(2013) Hongping Xia et al.   HEPATOLOGY

Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old Idea

(2013) David E. Gerber et al.   JOURNAL OF CLINICAL ONCOLOGY

Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway

(2013) Yan Wang et al.   PLoS One

Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

(2013) Xiaofeng Chen et al.   PLoS One

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

(2013) Shanthi Ganesh et al.   Molecular Therapy-Nucleic Acids

MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5

(2012) Xiang-hua Liu et al.   BMC CANCER

microRNA regulation of cell viability and drug sensitivity in lung cancer

(2012) Liqin Du et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

(2012) Xin Fu et al.   FEBS LETTERS

Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion

(2012) Florence Grise et al.   HEPATOLOGY

MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1

(2012) M. Sun et al.   MOLECULAR CANCER THERAPEUTICS

IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer

(2012) M Cortés-Sempere et al.   ONCOGENE

Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells

(2011) Junjun Chen et al.   CHEMISTRY & BIOLOGY

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

(2011) Elisa Giovannetti et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)

(2011) Qi Wang et al.   EXPERIMENTAL LUNG RESEARCH

Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway

(2010) Jian Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA and drug resistance

(2010) J Ma et al.   CANCER GENE THERAPY

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance

(2010) Zhiwei Wang et al.   DRUG RESISTANCE UPDATES

Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer

(2010) T. G. Oliver et al.   GENES & DEVELOPMENT

Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine

(2010) N. Viñolas et al.   LUNG CANCER

Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin

(2010) S Wang et al.   ONCOGENE

microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis

(2009) A. E. Hoffman et al.   CANCER RESEARCH

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

(2009) Tetsuya Mitsudomi et al.   LANCET ONCOLOGY

miR-138 might reverse multidrug resistance of leukemia cells

(2009) Xiaohong Zhao et al.   LEUKEMIA RESEARCH

High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells

(2009) Carl Christoph Schimanski et al.   WORLD JOURNAL OF GASTROENTEROLOGY

miR-196a Regulates Proliferation and Osteogenic Differentiation in Mesenchymal Stem Cells Derived From Human Adipose Tissue

(2008) Yeon Jeong Kim et al.   JOURNAL OF BONE AND MINERAL RESEARCH